Yes, must be getting an announcement tomorrow prior to the briefing session in the afternoon.
There's no way MST could know this / present this otherwise. Seems bizarre to publish this updated clinical program, I would have thought the clinical P1a/b data would inform future programs? This could all be out the window again in 6 months...
We haven't heard anything about melanoma since June 2022:
https://raceoncology.com/zantrene-improves-cancer-immunotherapy-in-a-mouse-model-of-treatment-resistant-melanoma/
Keytruda synergy pls....
Ann: Race In-person Investor Briefing Invitation Perth, page-12
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.83 |
Change
-0.030(1.61%) |
Mkt cap ! $311.7M | |||
| Open | High | Low | Value | Volume |
| $1.86 | $1.91 | $1.79 | $169.3K | 92.02K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 92 | $1.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.87 | 3472 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |